-+ 0.00%
-+ 0.00%
-+ 0.00%

Barrington Research Maintains Outperform on Orthofix Medical, Lowers Price Target to $15

Benzinga·05/22/2026 12:47:43
Listen to the news
Barrington Research analyst Michael Petusky maintains Orthofix Medical (NASDAQ:OFIX) with a Outperform and lowers the price target from $17 to $15.